| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.17 | 0.7 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |